| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | CA2673615C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 07/16/2013 | CA2620026C Method for production of single- and multi-layer microcapsules |
| 07/16/2013 | CA2486106C Compounds and methods for inhibiting selectin-mediated function |
| 07/16/2013 | CA2477283C Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 07/16/2013 | CA2458476C Photoreactive compounds and compositions |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2253441C Glycoprotein hormone superagonists |
| 07/11/2013 | WO2013103089A1 Culture method for maintenance and propagation of stem cells by lysophospholipid signal control |
| 07/11/2013 | US20130177588 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 07/10/2013 | EP2612919A1 Sulfated polysaccharide capable of binding to growth factor and use thereof |
| 07/10/2013 | EP2612914A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient |
| 07/10/2013 | EP2612673A1 Intestine immunomodulator |
| 07/10/2013 | EP2612669A2 Use of the fetal reprogramming of a ppar agonist |
| 07/10/2013 | EP2611439A1 Composition comprising a combination of dha and epa for administration prior to commencement of chemotherapy |
| 07/10/2013 | CN1541109B Inhibitors of HER3 activity |
| 07/10/2013 | CN103201270A P2x4 receptor antagonist |
| 07/10/2013 | CN103200939A Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy |
| 07/10/2013 | CN103194489A Novel cationic liposome nucleic acid pharmaceutical preparation as well as preparation method and application thereof |
| 07/10/2013 | CN103191303A Traditional Chinese medicine for treating night sweat |
| 07/10/2013 | CN103191262A Medicine for treating hernia and preparation method thereof |
| 07/10/2013 | CN103191068A Catechin lozenge and its making method |
| 07/10/2013 | CN102327304B Drug for preventing and controlling chronic mountain sickness and preparation method thereof |
| 07/10/2013 | CN102099354B Azole compound |
| 07/10/2013 | CN101679242B Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 07/10/2013 | CN101253166B Sulfonamide compound |
| 07/09/2013 | USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481512 Compositions and methods for modulation of vascular structure and/or function |
| 07/09/2013 | US8481070 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2682736C Combined use of dipeptidyl peptidase 4 inhibitor and sweetener |
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4 |
| 07/09/2013 | CA2516407C Heteroarylcarbamoylbenzene derivatives |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013101830A1 2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators |
| 07/04/2013 | WO2013101600A1 Cinnamic acid hydroxyamides as inhibitors of histone deacetylase 8 |
| 07/04/2013 | WO2013098331A1 Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins c3a/c4a, and chemotactic factors |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130171187 Glucan-based vaccines |
| 07/04/2013 | US20130171168 Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors |
| 07/04/2013 | US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth |
| 07/04/2013 | CA2861247A1 Antisense nucleic acids |
| 07/04/2013 | CA2861202A1 Novel nicotinamide derivative or salt thereof |
| 07/03/2013 | EP2610619A1 Hemokinin-1 receptor and hemokinin-1-derived peptide |
| 07/03/2013 | EP2610254A1 Deuterated benzoquinoline derivatives as inhibitors of vesicular monoamine transporter 2 |
| 07/03/2013 | EP2610249A1 Pluripotent stem cell cardiomyocyte differentiation-promoting agent |
| 07/03/2013 | EP2610248A1 Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound |
| 07/03/2013 | EP2609927A1 Cytoprotective agent |
| 07/03/2013 | CN103189350A Trans-2-decenoic acid derivative and medicament containing same |
| 07/03/2013 | CN103184209A Homosapiensarginase and pegylation homosapiensarginase as well as applications thereof |
| 07/03/2013 | CN103183725A A method of detecting protein lysine crotonylation acylation modification and developing affinity reagents |
| 07/03/2013 | CN103181951A Application of pseudo-ginseng and maca composition to treatment of dizziness, headache and hand-foot numbness |
| 07/03/2013 | CN103181913A 一种胡椒碱自乳化软胶囊及其制备方法 One kind of self-emulsifying soft capsules piperine and its preparation method |
| 07/03/2013 | CN103181564A Nutritional composition for immune condition |
| 07/03/2013 | CN101501193B Methods and means for treating DNA repeat instability associated genetic disorders |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/03/2013 | CN101035530B VEGF inhibition |
| 07/02/2013 | USRE44338 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/02/2013 | US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 07/02/2013 | US8476262 Cyanopyrroles |
| 07/02/2013 | US8476260 Antitumor agent |
| 07/02/2013 | US8476220 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/02/2013 | US8475850 Methods and compositions for heavy metal detoxification |
| 07/02/2013 | US8475834 Method of improving absorption of vitamin E by a pet animal |
| 07/02/2013 | CA2560559C Aqueous intraocular penetration-promoting eye drop |
| 07/02/2013 | CA2504582C Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer |
| 07/02/2013 | CA2470964C Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/02/2013 | CA2445729C Use of metals to treat mucosal membranes |
| 07/02/2013 | CA2373178C The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 07/02/2013 | CA2251009C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/27/2013 | WO2013094761A1 Novel s1p receptor modulator |
| 06/27/2013 | WO2013094682A1 Local-administration-type medicinal agent for ameliorating deglutition disorder |
| 06/27/2013 | WO2013094676A1 Hydroxymethylfurfural derivative |
| 06/27/2013 | WO2013094574A1 Mixed valence copper compound-loaded tungsten oxide and method for producing same |
| 06/27/2013 | WO2013094573A1 Copper-and-titanium-containing composition and production method therefor |
| 06/27/2013 | WO2013094572A1 Copper-and-titanium-containing composition and production method therefor |
| 06/27/2013 | WO2013093878A1 A conditioned medium obtained from placental mesenchymal stem cells and use thereof in the therapeutic treatment of preeclampsia |
| 06/27/2013 | US20130165634 Expression and export of angiogenesis inhibitors as immunofusins |
| 06/27/2013 | US20130165503 Method for Treating Ocular Neovascularization |
| 06/27/2013 | US20130164292 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors |
| 06/27/2013 | US20130164255 Immunotherapy for reversing immune suppression |
| 06/26/2013 | EP2607360A1 4-isopropyl-6-methoxyphenyl glucitol compound |
| 06/26/2013 | EP2606909A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom |
| 06/26/2013 | EP2606886A1 Composition containing tetracyclic compound |
| 06/26/2013 | EP2606882A1 Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 06/26/2013 | CN103180441A Skin and hair color-controlling factor |
| 06/26/2013 | CN103180315A Method of treatment for mental disorders |
| 06/26/2013 | CN103179975A Intestine immunomodulator |
| 06/26/2013 | CN103173480A Method for screening multidrug resistance related microRNA (ribonucleic acid) by using dual-luciferase report genes |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |